Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Hydrogel-based Drug Delivery System Market Snapshot (2022-2032)

[250 Pages Report] Newly-released Hydrogel-based Drug Delivery System Market analysis report by Future Market Insights shows that global sales of Hydrogel-based Drug Delivery System in 2021 were held at US$ 6.7 Bn. With 8.8%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth.

Attributes Details
Hydrogel-based drug delivery systems market CAGR (2022 to 2032) 8.8%
Hydrogel-based drug delivery systems market Size (2022) US$ 7.2 Billion
Hydrogel-based drug delivery systems market Size (2032) US$ 16.8 Billion

Hybrid polymer type is expected to be the highest revenue generating segment, projected to grow at a CAGR of over 8.5% during 2022 – 2032. The absolute dollar growth value for global market is US$ 9.5 Bn.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Revenue of Hydrogel-based drug delivery systems market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Hydrogel-based drug delivery systems market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, market value of the Hydrogel-based drug delivery systems market increased at around 7.7% CAGR. The demand for hydrogel-based drug delivery systems is expected to increase due to the high drug loading capacity coupled with benefits such as targeted delivery and focused distribution.

Dose sparing, fewer adverse effects, decreased medication administration frequency, and improved patient compliance are all benefits of formulating pharmacological molecules as controlled drug release. Hydrogels are attractive medication carriers due to their simplicity of manufacturing and self-application characteristic.

Ferring B.V. gained approval from Japan's Minister of Health, Labor and Welfare (MHLW) to commercialise its hydrogel-based drug delivery system for cervical ripening in January 2020. The clearance is likely to considerably increase the company's income as Japan is a profitable market for women's health and wellness. According to Future Market Insights, Hydrogel-based drug delivery systems market revenue would increase 2.3X between 2022 and 2032, reaching roughly US$ 16.8 Bn in 2032.

What Factors are Propelling Hydrogel-based Drug Delivery Demand?

Increased investment and expenditure in R&D operations by leading pharmaceutical firms in search of novel medications, delivery systems, and diagnostics is expected to drive the market for hydrogel-based drug delivery systems in the coming years. A pharmaceutical company's capacity to generate effective formulations determines its profitability. Since the pharmaceutical sector is extremely fragmented and competitive, large expenditures in R&D are undertaken to stay competitive.

Pharmaceutical businesses spend about 15-20% of their annual revenue on research and development. Because of its superior physical qualities, hydrogel is a potential medication delivery technology. The market is expected to be driven by increased R&D activity related to medication delivery systems.

Factors that are projected to accelerate market growth include an increase in the number of studies to enhance hydrogel-based protein delivery, surge in CNS illnesses, and an increase in funding for hydrogel-based drug delivery systems.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the restraints of Hydrogel-based drug delivery systems market?

Compatibility issues with some of the medicines and high cost of hydrogels are the key challenges that are expected to reduce the market growth in the long run. Also, the difficulty of producing a hydrogel with a consistent surface area may slow down its acceptance.

Which Region is projected to Offer the Largest Opportunity for Hydrogel-based Drug Delivery?

North America held the largest hydrogel-based drug delivery systems market, accounting for a market size of US$ 2.9 Bn in 2021. The presence of effective reimbursement that covers the cost of therapies, the presence of hydrogel suppliers in the region, and frequent product introductions are all projected to contribute to the region's market growth. Dare Bioscience, a biopharmaceutical firm based in the United States, announced its findings from clinical trials conducted to access medication delivery (clindamycin phosphate 2%) utilizing biocompatible hydrogel in the control of infections vaginosis.

Over the projected period, the market for hydrogel-based drug delivery systems in Asia Pacific is expected to develop at the fastest pace. The presence of a large target population, improved access to healthcare, augmented requirement for better medical treatment in numerous therapeutic area, and rising demand to reduce healthcare costs are expected to drive market expansion in the upcoming years.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which Polymer type of Hydrogel-based Drug Delivery is expected to Score Highest Growth in the Coming Years?

Natural hydrogels that are made from proteins like gelatin, lysosomes, and collagen, as well as polysaccharides like chitosan, hyaluronic acid, and alginate offer high cell adhesion quality, however they are less commonly used in drug delivery systems caused by mechanical and stability concerns.

Hydrogel-based drug delivery made of synthetic polymer are preferred owing to its enhanced drug absorption capacity, superior mechanical qualities, increased lifetime, and regulated degradation features, hydrogel-based drug delivery systems are gaining more popularity than naturally produced polymer but the hybrid segment is expected to score highest growth in the coming years.

The hybrid segment dominated the hydrogel-based drug delivery systems market, accounting for 6.6% CAGR in 2021. Hybrid hydrogels are made by combining natural and synthetic hydrogels. In the production of an upgraded version known as SMART hydrogel, the phenomenon of hybrid polymerization is exploited.

The drug released in SMART hydrogels is reliant on physical or chemical stimuli, which distinguishes them from ordinary hydrogels. Temperature, pressure, magnetic field, and electric field are examples of physical stimuli that can be used to enable targeted drug delivery utilising hydrogels.

Which Delivery Route of Hydrogel-based Drug Delivery is expected to Score Highest Growth in the Coming Years?

The ocular segment dominated the market for hydrogel-based drug delivery systems, accounting for 8.7% CAGR in 2021. Since the toughest contact lenses are constructed of hydrogel films, hydrogels are extensively used in ocular medication delivery applications. As a result, medications can be easily included into contact lenses.

Dextenza and Lacriset are ocular medication delivery systems based on hydrogels that have been licenced for clinical usage. There are also a slew of active clinical trials for hydrogel contact lens-based medication delivery systems, which is propelling the market forward. The Massachusetts Eye and Ear Infirmary, for example, is undertaking a clinical experiment to see if dexamethasone can be delivered through a hydrogel contact lens.

Hydrogels are widely employed in the development of subcutaneous medication delivery systems because they are biodegradable. The implants decay spontaneously within the body, eliminating the need for surgical removal. To achieve the regulated release of anticancer medicines, many subcutaneous hydrogel implants have recently been designed.

Drugs are incorporated into a hydrogel to treat diseases of the mouth cavity such as fungal infection, gum disease, oral infections, and stomatitis locally. The hydrogel's good adhesion and stability properties with the oral cavity mucosa aid in local medication delivery. A hydrogel-based drug delivery system is employed in the delivery of medications in the oral cavity for this purpose. Other drug delivery channel segments that are predicted to develop at a promising rate over the projection period include transdermal, vaginal, and rectal.

What is the impact of Covid-19 on Hydrogel-based drug delivery systems market?

The imposed lockdown, travel ban, and other regulations have had a severe impact on different commercial sectors in the beginning of COVID-19. On the other hand, it has had a favourable impact on the hydrogel-based drug delivery system market, as different vaccine clinical trials require hydrogel, which is driving market expansion. Furthermore, several pharmaceutical organisations rely heavily on hydrogel to conduct their research efforts for novel drug development and other clinical trials.

As a result, demand for hydrogel-based drug delivery systems have surged, opening up new potential opportunities for the global market over the forecast period. A large number of studies analysing the development of COVID-19 vaccination using hydrogels have emphasised the potential prospects of hydrogel-based drug delivery systems.

Competitive Analysis

Clinical trials employing hydrogel-based drug delivery systems have shown promising results, motivating pharmaceutical companies to invest in such therapeutic strategies. According to a 2019 NCBI report, the hydrogel was employed in 223 clinical trials for medicinal or diagnostic purposes, excluding contact lens trials. In the 223 clinical trials, the hydrogel coil was employed in eight of them, the bulk hydrogel in 166, and the patch hydrogel in 99. The key players operating in Hydrogel-based drug delivery systems market include GALDERMA, Blairex Laboratories, Medtronic, Ocular Therapeutix, Ferring B.V., Johnson & Johnson, Endo International plc, Akorn, Incorporated, Bausch and Lomb, and Tolmar Pharmaceuticals.

Some of the recent developments of Hydrogel-based drug delivery systems market key providers are as follows:

  • In March 2021, Johnson & Johnson Vision has received approval from The Japanese Ministry of Health, Labour and Welfare (MHLW) for ACUVUE Theravision with Ketotifen, which is the world's first and only drug-releasing combination contact lens for vision correction and allergic eye itch.
  • In June 2021, Sol-Gel Technologies and Galderma announced that their EPSOLAY and TWYNEO will be commercialised in the United States. They also announced about the exclusive licenses between them.
  • In August 2020, Bausch + Lomb, a leading global eye health business of Bausch Health Companies, has launched the Bausch + Lomb INFUSETM silicone hydrogel daily disposable contact lens. It is the first silicone hydrogel daily disposable with a material infused with technology named ProBalance to improve ocular surface homeostasis and alleviate symptoms of contact lens dryness, which affects about half of the 45 Mn lens users in the U.S.

Hydrogel-based drug delivery systems market Report Scope

Attribute Details
Forecast Period 2022 to 2032
Historical Data Available for 2017 to 2021
Market Analysis US$ Billion for Value
Key Regions Covered North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Key Countries Covered United States, Canada, Brazil, Mexico, Germany, UK., France, Spain, Italy, Russia, China, Japan, South Korea, India, Australia, South Africa, Saudi Arabia, UAE and Israel.
Key Market Segments Covered Polymer Type, Delivery Route, Region
Key Companies Profiled
  • GALDERMA
  • Blairex Laboratories, Inc.
  • Johnson & Johnson
  • Bausch and Lomb
  • Medtronic
  • Ocular Therapeutix, Inc.
  • Ferring B.V.
  • Endo International plc
  • Akorn, Incorporated
  • Tolmar Pharmaceuticals, Inc.
Pricing Available upon Request

Market Segments Covered in Hydrogel-based drug delivery systems market Analysis

By Polymer Type:

  • Natural
  • Synthetic
  • Hybrid

By Delivery Route:

  • Subcutaneous
  • Ocular
  • Oral Cavity
  • Topical
  • Other Delivery Routes

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa(MEA)

Frequently Asked Questions

How much is the current worth of the Hydrogel-based drug delivery systems market?

The Global Hydrogel-based drug delivery systems market is worth more than US$ 6.7 Bn at present.

What is the sales forecast for Hydrogel-based drug delivery systems market?

Value of Hydrogel-based drug delivery systems market is projected to increase at a CAGR of around 8.8% during 2022 – 2032.

What was the last 5 year’s market CAGR?

Value of Hydrogel-based drug delivery systems market increased at a CAGR of around 7.7% during 2017 – 2021.

What is a key trend shaping the growth of the Hydrogel-based drug delivery systems market?

The key trends shaping the growth of the market for hydrogel-based drug delivery systems in the coming years is increased investment and funding by leading pharmaceutical companies in R&D operations in quest of novel drugs, delivery systems, and diagnostics.

At what percentage are sales of Hydrogel-based drug delivery systems market expected to register growth in China?

The market for Hydrogel-based Drug Delivery in China is projected to expand at a CAGR of around 11.5% during 2022 – 2032.

What do statistics for South Korea and Japan reveal?

While the market in South Korea is expected to grow at nearly 9.8%, the market in Japan is projected to register a CAGR of nearly 11.5% during 2022 - 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Polymer Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Polymer Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Polymer Type, 2022-2032

        5.3.1. Natural

        5.3.2. Synthetic

        5.3.3. Hybrid

    5.4. Y-o-Y Growth Trend Analysis By Polymer Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Polymer Type, 2022-2032

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Delivery Route

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Delivery Route, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Delivery Route, 2022-2032

        6.3.1. Subcutaneous

        6.3.2. Ocular

        6.3.3. Oral Cavity

        6.3.4. Topical

        6.3.5. Other Delivery Routes

    6.4. Y-o-Y Growth Trend Analysis By Delivery Route, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Delivery Route, 2022-2032

7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Polymer Type

        8.2.3. By Delivery Route

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Polymer Type

        8.3.3. By Delivery Route

    8.4. Key Takeaways

9. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Polymer Type

        9.2.3. By Delivery Route

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Polymer Type

        9.3.3. By Delivery Route

    9.4. Key Takeaways

10. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. Italy

            10.2.1.3. France

            10.2.1.4. U.K.

            10.2.1.5. Spain

            10.2.1.6. Russia

            10.2.1.7. BENELUX

            10.2.1.8. Rest of Europe

        10.2.2. By Polymer Type

        10.2.3. By Delivery Route

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Polymer Type

        10.3.3. By Delivery Route

    10.4. Key Takeaways

11. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. India

            11.2.1.5. Rest of Asia Pacific

        11.2.2. By Polymer Type

        11.2.3. By Delivery Route

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Polymer Type

        11.3.3. By Delivery Route

    11.4. Key Takeaways

12. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. GCC

            12.2.1.2. Rest of MEA

        12.2.2. By Polymer Type

        12.2.3. By Delivery Route

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Polymer Type

        12.3.3. By Delivery Route

    12.4. Key Takeaways

13. Key Countries Market Analysis

    13.1. U.S.

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Polymer Type

            13.1.2.2. By Delivery Route

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Polymer Type

            13.2.2.2. By Delivery Route

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Polymer Type

            13.3.2.2. By Delivery Route

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Polymer Type

            13.4.2.2. By Delivery Route

    13.5. Argentina

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Polymer Type

            13.5.2.2. By Delivery Route

    13.6. Germany

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Polymer Type

            13.6.2.2. By Delivery Route

    13.7. Italy

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Polymer Type

            13.7.2.2. By Delivery Route

    13.8. France

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Polymer Type

            13.8.2.2. By Delivery Route

    13.9. U.K.

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Polymer Type

            13.9.2.2. By Delivery Route

    13.10. Spain

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Polymer Type

            13.10.2.2. By Delivery Route

    13.11. Russia

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Polymer Type

            13.11.2.2. By Delivery Route

    13.12. BENELUX

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Polymer Type

            13.12.2.2. By Delivery Route

    13.13. China

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Polymer Type

            13.13.2.2. By Delivery Route

    13.14. Japan

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Polymer Type

            13.14.2.2. By Delivery Route

    13.15. South Korea

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Polymer Type

            13.15.2.2. By Delivery Route

    13.16. India

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2021

            13.16.2.1. By Polymer Type

            13.16.2.2. By Delivery Route

    13.17. GCC Countries

        13.17.1. Pricing Analysis

        13.17.2. Market Share Analysis, 2021

            13.17.2.1. By Polymer Type

            13.17.2.2. By Delivery Route

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Polymer Type

        14.3.3. By Delivery Route

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. GALDERMA

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segment

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

                15.1.1.5.2. Product Strategy

        15.1.2. Blairex Laboratories, Inc.

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segment

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

                15.1.2.5.2. Product Strategy

        15.1.3. Johnson & Johnson

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segment

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

                15.1.3.5.2. Product Strategy

        15.1.4. Bausch & Lomb

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segment

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

                15.1.4.5.2. Product Strategy

        15.1.5. Medtronic

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segment

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

                15.1.5.5.2. Product Strategy

        15.1.6. Ocular Therapeutix, Inc.

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segment

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

                15.1.6.5.2. Product Strategy

        15.1.7. Ferring B.V.

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segment

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

                15.1.7.5.2. Product Strategy

        15.1.8. Endo International, Plc.

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segment

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

                15.1.8.5.2. Product Strategy

        15.1.9. Akorn, Inc.

            15.1.9.1. Overview

            15.1.9.2. Product Portfolio

            15.1.9.3. Profitability by Market Segment

            15.1.9.4. Sales Footprint

            15.1.9.5. Strategy Overview

                15.1.9.5.1. Marketing Strategy

                15.1.9.5.2. Product Strategy

        15.1.10. Tolmar Pharmaceuticals, Inc.

            15.1.10.1. Overview

            15.1.10.2. Product Portfolio

            15.1.10.3. Profitability by Market Segment

            15.1.10.4. Sales Footprint

            15.1.10.5. Strategy Overview

                15.1.10.5.1. Marketing Strategy

                15.1.10.5.2. Product Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Recommendations

Healthcare

Therapeutic Drug Monitoring Market

Published : April 2024

Healthcare

Injectable Drug Delivery Market

Published : April 2024

Healthcare

Drug Delivery Technology Market

Published : August 2023

Healthcare

Breast Cancer Drug Market

Published : July 2023

Explore Healthcare Insights

View Reports

Hydrogel-based Drug Delivery System Market